Literature DB >> 7625800

Effects of penicillin, ceftriaxone, and doxycycline on morphology of Borrelia burgdorferi.

A Kersten1, C Poitschek, S Rauch, E Aberer.   

Abstract

Antibiotic therapy with penicillin, doxycycline, and ceftriaxone has proven to be effective for the treatment of Lyme borreliosis. In some patients, however, it was noticed that borreliae can survival in the tissues in spite of seemingly adequate therapy. For a better understanding of this phenomenon, we investigated the different modes of degeneration of Borrelia burgdorferi suspensions during a 96-h exposure to various antibiotics. By dark-field microscopy and ultrastructural investigations, increasing blebbing and the gradual formation of granular and cystic structures could be followed during the exposure time. Although antibiotic concentrations at the MIC at which 90% of organisms are inhibited after 72 h were 80% or even greater, motile organisms were still present after incubation with penicillin and doxycycline but not after incubation with ceftriaxone. By transmission electron microscopy, intact spirochetal parts, mostly situated in cysts, were seen up to 96 h after exposure with all three antibiotics tested. According to experiences from studies with other spirochetes it is suggested that encysted borreliae, granules, and the remaining blebs might be responsible for the ongoing antigenic stimulus leading to complaints of chronic Lyme borreliosis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7625800      PMCID: PMC162695          DOI: 10.1128/AAC.39.5.1127

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  28 in total

1.  Survival of Borrelia burgdorferi in antibiotically treated patients with Lyme borreliosis.

Authors:  V Preac-Mursic; K Weber; H W Pfister; B Wilske; B Gross; A Baumann; J Prokop
Journal:  Infection       Date:  1989 Nov-Dec       Impact factor: 3.553

2.  New chemotherapeutic approaches in the treatment of Lyme borreliosis.

Authors:  B J Luft; D J Volkman; J J Halperin; R J Dattwyler
Journal:  Ann N Y Acad Sci       Date:  1988       Impact factor: 5.691

3.  Survival of treponemes after treatment: comments, clinical conclusions, and recommendations.

Authors:  E M Dunlop
Journal:  Genitourin Med       Date:  1985-10

4.  Antibiotic therapy in early erythema migrans disease and related disorders.

Authors:  K Weber; U Neubert; R Thurmayr
Journal:  Zentralbl Bakteriol Mikrobiol Hyg A       Date:  1987-02

5.  In vitro and in vivo susceptibility of Borrelia burgdorferi.

Authors:  V P Mursic; B Wilske; G Schierz; M Holmburger; E Süss
Journal:  Eur J Clin Microbiol       Date:  1987-08       Impact factor: 3.267

6.  Action of penicillin on Borrelia hermsii.

Authors:  A G Barbour; W J Todd; H G Stoenner
Journal:  Antimicrob Agents Chemother       Date:  1982-05       Impact factor: 5.191

7.  Colony formation and morphology in Borrelia burgdorferi.

Authors:  T J Kurtti; U G Munderloh; R C Johnson; G G Ahlstrand
Journal:  J Clin Microbiol       Date:  1987-11       Impact factor: 5.948

8.  European Borrelia burgdorferi isolated from humans and ticks culture conditions and antibiotic susceptibility.

Authors:  V Preac-Mursic; B Wilske; G Schierz
Journal:  Zentralbl Bakteriol Mikrobiol Hyg A       Date:  1986-12

9.  Ultrastructural differences among spirochetes isolated from patients with Lyme disease and related disorders, and from Ixodes ricinus.

Authors:  K Hovind-Hougen; E Asbrink; G Stiernstedt; A C Steere; A Hovmark
Journal:  Zentralbl Bakteriol Mikrobiol Hyg A       Date:  1986-12

10.  Mechanism of penicillin killing in the absence of bacterial lysis.

Authors:  T D McDowell; K E Reed
Journal:  Antimicrob Agents Chemother       Date:  1989-10       Impact factor: 5.191

View more
  31 in total

1.  Isolation of a potent antibiotic producer bacterium, especially against MRSA, from northern region of the Persian Gulf.

Authors:  Esmaeil Darabpour; Mohammad Roayaei Ardakani; Hossein Motamedi; Mohammad Taghi Ronagh
Journal:  Bosn J Basic Med Sci       Date:  2012-05       Impact factor: 3.363

2.  Lectin-binding characteristics of a Lyme borreliosis spirochete Borrelia burgdorferi sensu stricto.

Authors:  M Vancová; J Nebesárová; L Grubhoffer
Journal:  Folia Microbiol (Praha)       Date:  2005       Impact factor: 2.099

3.  In vitro activity of trimethoprim against Borrelia burgdorferi.

Authors:  E C Reisinger; I Wendelin; R Gasser
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-06       Impact factor: 3.267

Review 4.  Evidence assessments and guideline recommendations in Lyme disease: the clinical management of known tick bites, erythema migrans rashes and persistent disease.

Authors:  Daniel J Cameron; Lorraine B Johnson; Elizabeth L Maloney
Journal:  Expert Rev Anti Infect Ther       Date:  2014-07-30       Impact factor: 5.091

Review 5.  A systematic review of Borrelia burgdorferi morphologic variants does not support a role in chronic Lyme disease.

Authors:  Paul M Lantos; Paul G Auwaerter; Gary P Wormser
Journal:  Clin Infect Dis       Date:  2013-12-12       Impact factor: 9.079

6.  In vitro activities of fluoroquinolones against the spirochete Borrelia burgdorferi.

Authors:  P Kraiczy; J Weigand; T A Wichelhaus; P Heisig; H Backes; V Schäfer; G Acker; V Brade; K P Hunfeld
Journal:  Antimicrob Agents Chemother       Date:  2001-09       Impact factor: 5.191

7.  Formation and cultivation of Borrelia burgdorferi spheroplast-L-form variants.

Authors:  V P Mursic; G Wanner; S Reinhardt; B Wilske; U Busch; W Marget
Journal:  Infection       Date:  1996 May-Jun       Impact factor: 3.553

8.  Success and failure in the treatment of acrodermatitis chronica atrophicans.

Authors:  E Aberer; F Breier; G Stanek; B Schmidt
Journal:  Infection       Date:  1996 Jan-Feb       Impact factor: 3.553

9.  Erythema migrans: three weeks treatment for prevention of late Lyme borreliosis.

Authors:  F Breier; G Kunz; H Klade; G Stanek; E Aberer
Journal:  Infection       Date:  1996 Jan-Feb       Impact factor: 3.553

10.  Destruction of spirochete Borrelia burgdorferi round-body propagules (RBs) by the antibiotic tigecycline.

Authors:  Øystein Brorson; Sverre-Henning Brorson; John Scythes; James MacAllister; Andrew Wier; Lynn Margulis
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-20       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.